16 November 2020
Spanish pharmaceuticals company Reig Jofre will be able to produce 50 million doses of COVID-19 vaccine a year at its new factory without cancelling any existing contracts, it said on Friday.
The company’s new plant in Barcelona is under construction and due to start operating in the second quarter of 2021, Reig Jofre said in a statement.
Reig Jofre CEO Ignasi Biosca had said in the summer that the company was ready to invest an additional 2-3 million euros to adapt its new plant for the final step in the production process of putting the COVID-19 vaccine into vials or syringes, such as guaranteeing the low temperature needed to preserve the vaccine.
The company, which manufactures and conditions antibiotics, injectables and other healthcare products, also said that nine-month net profit more than doubled to 5.3 million euros on sales of 170 million euros.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024